Filter
761
Filtered Results: 761
Text search:
World
Health
Organization
WHO,
Regional
Office
for
Eastern
Mediterranen
Featured
Recommendations
110
New Publications
152
Language
Document type
No document type
257
Studies & Reports
201
Guidelines
136
Manuals
68
Strategic & Response Plan
40
Training Material
16
Fact sheets
14
Situation Updates
13
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
72
Syria
24
Africa
21
Middle East and North Africa
19
Western and Central Europe
16
Yemen
9
Somalia
9
Latin America and the Carribbean
7
South–East Asia Region
7
Sudan
7
West and Central Africa
6
Eastern Europe
6
Pakistan
6
Nigeria
5
Ethiopia
5
Sierra Leone
4
Iran
4
Afghanistan
4
Jordan
4
Eastern Europe and Central Asia
4
East and Southern Africa
4
Lebanon
4
Iraq
4
Liberia
4
India
4
Myanmar / Burma
4
Kenya
3
Turkey
3
Ghana
3
Rwanda
3
Asia
3
Saudi Arabia
3
North Macedonia
2
Nepal
2
Thailand
2
Ukraine
2
China
2
Senegal
2
Venezuela
2
Bangladesh
2
South Africa
2
Uganda
2
Libya
2
Benin
1
Cameroon
1
Albania
1
Morocco
1
Qatar
1
Philippines
1
USA
1
Cambodia
1
Croatia
1
Tanzania
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Tunisia
1
Sri Lanka
1
Russia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
102
Countries
94
Public Health
82
Women & Child Health
69
Key Resources
55
Capacity Building
24
Pharmacy & Technologies
14
Toolboxes
Mental Health
86
COVID-19
79
Rapid Response
47
Planetary Health
46
TB
41
HIV
38
NTDs
38
Caregiver
32
Conflict
31
Refugee
30
AMR
29
Global Health Education
28
Disability
26
NCDs
24
Pharmacy
19
Malaria
15
Ebola & Marburg
12
Polio
11
Cholera
8
Zika
7
Natural Hazards
5
Health Financing Toolbox
5
Specific Hazards
4
Social Ethics
1
Typhoon
1
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
In fragile, conflict-affected and vulnerable settings, delivery of quality health services faces significant challenges, including disruption of a routine health service organization and delivery systems, increased health needs, complex and unpredictable resourcing issues, and vulnerability to multi...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The report provides a global knowledge base on suicide and suicide attempts as well as actionable steps for countries based on their current resources and context to move forward in suicide prevention.
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Provides clinical descriptions, diagnostic guidelines, and codes for all mental and behavioural disorders commonly encountered in clinical psychiatry. The book was developed from chapter V of the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (...
The toolkit provides practical guidance and tools that can support efforts, including planning and implementation activities, to create dementia-inclusive societies.
The toolkit is divided into two parts. Part I contains background information and a conceptual framework for creating dementia-incl...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
The Tripartite AMR Country Self-Assessment Survey (TrACSS) helps to monitor country progress on the implementation of AMR national actions plans and has been administered on an annual basis by the Tripartite organizations (Food and Agriculture Organization of the United Nations (FAO), World Organisa...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
